These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24718961)

  • 41. Imaging of gout: an overview.
    Dalbeth N; Doyle AJ
    Best Pract Res Clin Rheumatol; 2012 Dec; 26(6):823-38. PubMed ID: 23273794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for hyperuricaemia and gout: a perspective and research agenda.
    Stamp L; Dalbeth N
    Nat Rev Rheumatol; 2014 Dec; 10(12):752-6. PubMed ID: 25136783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperuricemia and gout.
    Lioté F
    Curr Rheumatol Rep; 2003 Jun; 5(3):227-34. PubMed ID: 12744816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities.
    Stamp LK; Wells JE; Pitama S; Faatoese A; Doughty RN; Whalley G; Richards AM; Cameron VA
    Intern Med J; 2013 Jun; 43(6):678-84. PubMed ID: 23279108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current management of gout].
    Miguel C; Mediavilla MJ
    Acta Med Port; 2011; 24(5):791-8. PubMed ID: 22525631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New insights into the epidemiology of gout.
    Doherty M
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperuricaemia: more than just a cause of gout?
    Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gout].
    Carey Berner I; Dudler J
    Rev Med Suisse; 2006 Jan; 2(48):160-2. PubMed ID: 16463802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Physiology and dynamics of uric acid in hyperuricemia].
    Takagi K; Nakamura T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent advances in the pathophysiology of hyperuricemia and gout].
    So A
    Rev Med Suisse; 2007 Mar; 3(103):720, 722-4. PubMed ID: 17458149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of gout: an update.
    Smith EU; Díaz-Torné C; Perez-Ruiz F; March LM
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):811-27. PubMed ID: 21665128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gout: an update.
    Eggebeen AT
    Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of hyperuricemia and gout in CKD.
    Gaffo AL; Saag KG
    Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of fruit consumption in patients with hyperuricaemia or gout.
    Nakagawa T; Lanaspa MA; Johnson RJ
    Rheumatology (Oxford); 2019 Jul; 58(7):1133-1141. PubMed ID: 31004140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
    Bursill D; Taylor WJ; Terkeltaub R; Kuwabara M; Merriman TR; Grainger R; Pineda C; Louthrenoo W; Edwards NL; Andrés M; Vargas-Santos AB; Roddy E; Pascart T; Lin CT; Perez-Ruiz F; Tedeschi SK; Kim SC; Harrold LR; McCarthy G; Kumar N; Chapman PT; Tausche AK; Vazquez-Mellado J; Gutierrez M; da Rocha Castelar-Pinheiro G; Richette P; Pascual E; Fisher MC; Burgos-Vargas R; Robinson PC; Singh JA; Jansen TL; Saag KG; Slot O; Uhlig T; Solomon DH; Keenan RT; Scire CA; Biernat-Kaluza E; Dehlin M; Nuki G; Schlesinger N; Janssen M; Stamp LK; Sivera F; Reginato AM; Jacobsson L; Lioté F; Ea HK; Rosenthal A; Bardin T; Choi HK; Hershfield MS; Czegley C; Choi SJ; Dalbeth N
    Arthritis Care Res (Hoboken); 2019 Mar; 71(3):427-434. PubMed ID: 29799677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tophaceous gout].
    Moriwaki Y
    Nihon Rinsho; 2008 Apr; 66(4):711-6. PubMed ID: 18409520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].
    Tausche AK; Manger B; Müller-Ladner U; Schmidt B
    Z Rheumatol; 2012 Apr; 71(3):224-30. PubMed ID: 22415625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2011 recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL
    Phys Sportsmed; 2011 Nov; 39(4):98-123. PubMed ID: 22293773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.